Biocorrx (OTCMKTS:BICX – Get Free Report) is expected to announce its resultson Tuesday, November 17th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $0.25 million for the quarter.
Biocorrx (OTCMKTS:BICX – Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. The company had revenue of $0.09 million during the quarter, compared to analyst estimates of $0.24 million.
Biocorrx Stock Performance
Shares of BICX opened at $0.20 on Tuesday. Biocorrx has a 52 week low of $0.15 and a 52 week high of $1.28. The stock’s 50-day moving average price is $0.22 and its 200-day moving average price is $0.31.
About Biocorrx
BioCorRx Inc is a healthcare company focused on solutions for individuals seeking recovery from alcohol and other substance-use disorders. Its principal offering, the BioCorRx Recovery Program, combines medical treatment with counseling, coaching, and ongoing support. The company has described the program as a non-addictive, medication-assisted recovery approach that may be delivered through participating treatment providers.
BioCorRx also develops and markets nutritional and wellness products intended to support recovery and overall health.
Further Reading
- Five stocks we like better than Biocorrx
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
